Abstract
Previous studies suggest that melatonin may act on cancer growth through a variety of mechanisms, most notably by direct anti-proliferative effects on breast cancer cells and via interactions with the estrogen pathway. Three genes are largely responsible for mediating the downstream effects of melatonin: melatonin receptors 1a and 1b (MTNR1a and MTNR1b), and arylalkylamine N-acetyltransferase (AANAT). It is hypothesized that genetic variation in these genes may lead to altered protein production or function. To address this question, we conducted a comprehensive evaluation of the association between common single nucleotide polymorphisms (SNPs) in the MTNR1a, MTNR1b, and AANAT genes and breast cancer risk among 2,073 cases and 2,083 controls, using a two-stage analysis of genome-wide association data among women of the Shanghai Breast Cancer Study. Results demonstrate two SNPs were consistently associated with breast cancer risk across both study stages. Compared with MTNR1b rs10765576 major allele carriers (GG or GA), a decreased risk of breast cancer was associated with the AA genotype (OR = 0.78, 95% CI = 0.62–0.97, P = 0.0281). Although no overall association was seen in the combined analysis, the effect of MTNR1a rs7665392 was found to vary by menopausal status (P-value for interaction = 0.001). Premenopausal women with the GG genotype were at increased risk for breast cancer compared with major allele carriers (TT or TG) (OR = 1.57, 95% CI = 1.07–2.31, P = 0.020), while postmenopausal women were at decreased risk (OR = 0.58, 95% 0.36–0.95, P = 0.030). No significant breast cancer associations were found for variants in the AANAT gene. These results suggest that common genetic variation in the MTNR1a and 1b genes may contribute to breast cancer susceptibility, and that associations may vary by menopausal status. Given that multiple variants in high linkage disequilibrium with MTNR1b rs76653292 have been associated with altered function or expression of insulin and glucose family members, further research may focus on clarifying this relationship.
Similar content being viewed by others
References
Brzezinski A (1997) Melatonin in humans. N Engl J Med 336(3):186–195
Aubert C, Janiaud P, Lecalvez J (1980) Effect of pinealectomy and melatonin on mammary tumor growth in Sprague-Dawley rats under different conditions of lighting. J Neural Transm 47(2):121–130
Tamarkin L, Cohen M, Roselle D et al (1981) Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. Cancer Res 41(11 Pt 1):4432–4436
Cohen M, Lippman M, Chabner B (1978) Role of pineal gland in aetiology and treatment of breast cancer. Lancet 2(8094):814–816
Klein D (1985) Photoneural regulation of the mammalian pineal gland. Photoperiodism, melatonin, and the pineal (Ciba Foundation Symposium 117). Pitman, London, pp 38–56
Axelrod J (1974) The pineal gland: a neurochemical transducer. Science 184(144):1341–1348
González A, Martínez-Campa C, Mediavilla MD et al (2007) Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells. Oncol Rep 17(4):947–953
Lai L, Yuan L, Cheng Q et al (2009) Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines. Breast Cancer Res Treat 118(2):293–305
Treeck O, Haldar C, Ortmann O (2006) Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines. Oncol Rep 15(1):231–235
Collins A, Yuan L, Kiefer TL et al (2003) Overexpression of the MT1 melatonin receptor in MCF-7 human breast cancer cells inhibits mammary tumor formation in nude mice. Cancer Lett 189(1):49–57
Takeuchi F, Katsuya T, Chakrewarthy S et al (2010) Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations. Diabetologia 53(2):299–308
Chambers JC, Zhang W, Zabaneh D et al (2009) Common genetic variation near melatonin receptor MTNR1B contributes to raised plasma glucose and increased risk of type 2 diabetes among Indian Asians and European Caucasians. Diabetes 58(11):2703–2708
Wang L, Wang Y, Zhang X et al (2010) Common genetic variation in MTNR1B is associated with serum testosterone, glucose tolerance, and insulin secretion in polycystic ovary syndrome patients. Fertil Steril 94(6):2486–2489, 2489.e1–2
Qiu XS, Tang NL, Yeung HY et al (2006) The role of melatonin receptor 1B gene (MTNR1B) in adolescent idiopathic scoliosis—a genetic association study. Stud Health Technol Inform 123:3–8
Ha E, Choe B, Jung KH et al (2005) Positive relationship between melatonin receptor type 1B polymorphism and rheumatoid factor in rheumatoid arthritis patients in the Korean population. J Pineal Res 39(2):201–205
Zheng W, Long J, Gao Y et al (2009) Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 41(3):324–328
Gao YT, Shu XO, Dai Q et al (2000) Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer 87(2):295–300
Yu K, Li Q, Bergen AW et al (2009) Pathway analysis by adaptive combination of P-values. Genet Epidemiol 33(8):700–709
Wang H, Wu Z, Zhuang Q et al (2008) Association study of tryptophan hydroxylase 1 and arylalkylamine N-acetyltransferase polymorphisms with adolescent idiopathic scoliosis in Han Chinese. Spine 33(20):2199–2203
Lai I, Chen M, Wang Y et al (2011) Analysis of genetic variations in the human melatonin receptor (MTNR1A, MTNR1B) genes and antipsychotics-induced tardive dyskinesia in schizophrenia. World J Biol Psychiatry 12(2):143–148
Nelson LM, Ward K, Ogilvie JW (2011) Genetic variants in melatonin synthesis and signaling pathway are not associated with adolescent idiopathic scoliosis. Spine 36(1):37–40
Girgert R, Hanf V, Emons G, Gründker C (2009) Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells. J Pineal Res 47(1):23–31
Chaste P, Clement N, Mercati O et al (2010) Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population. PLoS One 5(7):e11495
Li C, Shi Y, You L, Wang L, Chen Z (2011) Association of rs10830963 and rs10830962 SNPs in the melatonin receptor (MTNR1B) gene among Han Chinese women with polycystic ovary syndrome. Mol Hum Reprod 17(3):193–198
Staiger H, Machicao F, Schäfer SA et al (2008) Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function. PLoS One 3(12):e3962
Reiling E, van ‘t Riet E, Groenewoud MJ et al (2009) Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk. Diabetologia 52(9):1866–1870
Kelliny C, Ekelund U, Andersen LB et al (2009) Common genetic determinants of glucose homeostasis in healthy children: the European Youth Heart Study. Diabetes 58(12):2939–2945
Prokopenko I, Langenberg C, Florez JC et al (2009) Variants in MTNR1B influence fasting glucose levels. Nat Genet 41(1):77–81
Lyssenko V, Nagorny CLF, Erdos MR et al (2009) Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 41(1):82–88
Rönn T, Wen J, Yang Z et al (2009) A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals. Diabetologia 52(5):830–833
Sparsø T, Bonnefond A, Andersson E et al (2009) G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans. Diabetes 58(6):1450–1456
Langenberg C, Pascoe L, Mari A et al (2009) Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response. Diabetologia 52(8):1537–1542
Müssig K, Staiger H, Machicao F, Häring H, Fritsche A (2010) Genetic variants in MTNR1B affecting insulin secretion. Ann Med 42(6):387–393
Ciarleglio CM, Ryckman KK, Servick SV et al (2008) Genetic differences in human circadian clock genes among worldwide populations. J Biol Rhythms 23(4):330–340
Acknowledgments
Dr. Deming was supported by grants from the National Cancer Institute 5K99CA126978-02 and 4R00CA126978-03. In addition, this research was supported by R01CA064277 and R01CA124558. The authors wish to thank the participants and research staff of the Shanghai Breast Cancer Study for the contributions and commitment to this project and Bethanie Rammer and Jacqueline Stern for assistance with the preparation of this manuscript. Sample preparation and genotyping assays, using Affymetrix arrays, were conducted at the Survey and Biospecimen Shared Resource and the Vanderbilt Microarray Shared Resource, respectively, which was supported in part by the Vanderbilt-Ingram Cancer Center (P30CA68485).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Deming, S.L., Lu, W., Beeghly-Fadiel, A. et al. Melatonin pathway genes and breast cancer risk among Chinese women. Breast Cancer Res Treat 132, 693–699 (2012). https://doi.org/10.1007/s10549-011-1884-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-011-1884-5